Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18912 | 464 | 30.9 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
390 | 16316 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MINICHAL | Author keyword | 1 | 100% | 0% | 2 |
2 | ANTIHYPERTENSIVE DRUG CLASSES | Author keyword | 1 | 50% | 0% | 1 |
3 | ANTIHYPERTENSIVE REGIMENS | Author keyword | 1 | 50% | 0% | 1 |
4 | CAS 76547 98 3 | Author keyword | 1 | 50% | 0% | 1 |
5 | CHAIR CLIN PHARMACOL PHARMACOTHER Y | Address | 1 | 50% | 0% | 1 |
6 | ENALAPRIL HYDROCHLOROTHIAZIDE | Author keyword | 1 | 50% | 0% | 1 |
7 | EPIDEMIOL CLIN SALUT PUBL | Address | 1 | 50% | 0% | 1 |
8 | HUMAN ASSESSMENT | Address | 1 | 50% | 0% | 1 |
9 | ISOLATED OFFICE | Author keyword | 1 | 50% | 0% | 1 |
10 | MED CLIN TRIAL UNIT | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MINICHAL | 2 | 67% | 0% | 2 |
2 | PERCEIVED SYMPTOMS | 2 | 50% | 1% | 3 |
3 | QUESTIONNAIRE MINICHAL | 1 | 100% | 0% | 2 |
4 | THERAPEUTIC VARIABLES | 1 | 100% | 0% | 2 |
5 | TREATING MILD | 1 | 40% | 0% | 2 |
6 | EUR TRIAL | 1 | 20% | 1% | 4 |
7 | ALCOHOL DRINKING PATTERN | 1 | 50% | 0% | 1 |
8 | ENALAPRIL PLUS HYDROCHLOROTHIAZIDE | 1 | 50% | 0% | 1 |
9 | FELODIPINE METOPROLOL COMBINATION | 1 | 50% | 0% | 1 |
10 | MENTAL DISTRESS STATUS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies | 2011 | 31 | 27 | 52% |
Health-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000 | 2002 | 14 | 60 | 73% |
Health-related quality-of-life measurement in hypertension - A review of randomised controlled drug trials | 2000 | 11 | 95 | 54% |
Quality of life in cardiac patient research: A meta analysis | 1996 | 24 | 77 | 39% |
QUALITY-OF-LIFE AND ITS IMPACT ON HYPERTENSIVE PATIENTS | 1987 | 57 | 6 | 50% |
METHODS FOR QUALITY-OF-LIFE STUDIES | 1994 | 82 | 57 | 16% |
Effect of antihypertensive agents on quality of life in the elderly | 2004 | 42 | 95 | 24% |
QUALITY-OF-LIFE AND COST-EFFECTIVENESS IN THE TREATMENT OF HYPERTENSION | 1994 | 12 | 39 | 54% |
Methyldopa for primary hypertension | 2009 | 1 | 22 | 41% |
Effect of antihypertensive therapy on quality of life | 2003 | 0 | 18 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHAIR CLIN PHARMACOL PHARMACOTHER Y | 1 | 50% | 0.2% | 1 |
2 | EPIDEMIOL CLIN SALUT PUBL | 1 | 50% | 0.2% | 1 |
3 | HUMAN ASSESSMENT | 1 | 50% | 0.2% | 1 |
4 | MED CLIN TRIAL UNIT | 1 | 50% | 0.2% | 1 |
5 | NURSING HLTH AGING | 1 | 50% | 0.2% | 1 |
6 | RAK | 1 | 50% | 0.2% | 1 |
7 | RIBEIRAO PRETO MED OOL | 1 | 50% | 0.2% | 1 |
8 | UNITAT HIPERTENS | 1 | 50% | 0.2% | 1 |
9 | UNIV KLINIKUM BERLIN | 1 | 50% | 0.2% | 1 |
10 | EPIDEMIOL CLIN PLICAT NIH | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176875 | MRC TRIAL//ABORAT PREVENT TREATMENT CARDIOVASC DIS//CLIN EPIDEMIOL HLTH CARE PROGRAM MED |
2 | 0.0000152086 | APPOINTMENT NON ATTENDANCE//EBELTOFT HLTH PROMOT STUDY//MULTIPHASIC SCREENING |
3 | 0.0000116475 | SF 12//SF 36 HEALTH SURVEY//PHYSICAL FUNCTIONAL HEALTH |
4 | 0.0000116365 | INTEGRATED CARDIOVASC CLIN NETWORK SA//PREVENTAT HLTH//ANGIOTENSIN CONVERTING ENZYME INHIBITOR THERAPY |
5 | 0.0000112347 | RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL |
6 | 0.0000103481 | ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR |
7 | 0.0000101322 | CAS 89396 94 1//TA 6366//MOEXIPRIL |
8 | 0.0000097699 | HAIR DISTRIBUTION//PHYS ACT SPORT RECREAT PHASREC//HART |
9 | 0.0000097671 | VASCULAR RISK FACTORS//BRAIN HYPOPERFUSION//HOP BROCA |
10 | 0.0000086284 | AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY |